The Johns Hopkins Greenberg Bladder Cancer Institute, based in Baltimore, Maryland, is the first of its kind that is dedicated to improving the lives and outcomes of patients with bladder cancer and their families. In May 2014, the Institute was established with a $15 million gift from Baltimore-area commercial real estate developer Erwin L. Greenberg and his wife, Stephanie Cooper Greenberg — part of a $45 million co-investment with The Johns Hopkins University.
Learn More About What We Offer
-
Team members meet together in the clinic — weekly, though sometimes daily — to review your case: test results, treatment plans, progress, next steps. We believe that collaborative care will help you make the right informed decisions. This team approach allows for all of those caring for you across disciplines can offer their best informed opinion in a one-stop meeting to best review and support the best care options for you moving forward.
You can feel confident knowing that your care team is in sync.
-
The unique feature of our bladder cancer Multi-Disciplinary program is that patients have the opportunity to be in the same room as the many members of their care team. Our surgical and medical oncologists hold bladder cancer multi-disciplinary clinics on the same day at the same place, and even sit together to review options.
You can consult with both doctors when necessary, and care teams can streamline the scheduling, follow-up and research involved in each treatment plan.
-
As a global hub for advancing the understanding and treatment of bladder cancer, the Greenberg Institute is a leader in the latest research developments. We are eager to share that knowledge.
Our clinicians aren't just dedicated to patient care — they're renowned bladder cancer researchers actively working to develop new and better ways to fight the disease. With insight into newly available and on-the-horizon treatments, our team can offer suggestions on the suitability of clinical trial opportunities that may hold promise for many patients.
